A Prospective Phase II Clinical Trial of CD26/Dipeptidyl...

Biology of Blood and Marrow Transplantation 2020 / 03 Vol. 26; Iss. 3

A Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation.

Farag, Sherif S, Zaid, Mohammad Abu, Nelson, Robert P, Schwartz, Jennifer E, Thakrar, Teresa C, Huntley, Carol, Blakley, Anne J, Abonour, Rafat, Robertson, Michael J, Zhang, Shuhong
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.096
Date:
March, 2020
File:
PDF, 153 KB
2020
Conversion to is in progress
Conversion to is failed